Silicon Laboratories, Inc. (NASDAQ:SLAB) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Key Points

• Silicon Laboratories, Inc. has a consensus rating of "Moderate Buy" from eight research firms, with an average price target of $151.13.
• Recent earnings showed a revenue increase of 32.6% year-over-year, with a reported EPS of $0.11, above the consensus estimate.
• Analysts from KeyCorp and Barclays have increased their price targets for Silicon Laboratories, signaling confidence in the company's performance.

Silicon Laboratories, Inc. (NASDAQ:SLAB - Get Free Report) has received a consensus rating of "Moderate Buy" from the eight research firms that are currently covering the company, MarketBeat Ratings reports. Three analysts have rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 1 year price target among brokers that have issued a report on the stock in the last year is $151.1250.

Several research firms recently issued reports on SLAB. KeyCorp lifted their price objective on shares of Silicon Laboratories from $160.00 to $180.00 and gave the company an "overweight" rating in a research note on Tuesday, July 8th. Barclays lifted their price objective on shares of Silicon Laboratories from $100.00 to $130.00 and gave the company an "equal weight" rating in a research note on Tuesday, August 5th. Morgan Stanley reduced their price objective on shares of Silicon Laboratories from $157.00 to $144.00 and set an "equal weight" rating for the company in a research note on Wednesday, August 6th. Benchmark reaffirmed a "buy" rating and issued a $160.00 price objective on shares of Silicon Laboratories in a research note on Tuesday, May 27th. Finally, Stifel Nicolaus lifted their price objective on shares of Silicon Laboratories from $144.00 to $160.00 and gave the company a "buy" rating in a research note on Friday, July 18th.

Silicon Laboratories Stock Down 0.1%

Silicon Laboratories stock opened at $136.99 on Tuesday. The company's fifty day simple moving average is $135.25 and its 200-day simple moving average is $126.26. Silicon Laboratories has a 12 month low of $82.82 and a 12 month high of $160.00. The stock has a market cap of $4.49 billion, a P/E ratio of -42.54 and a beta of 1.52.

Silicon Laboratories (NASDAQ:SLAB - Get Free Report) last posted its quarterly earnings results on Tuesday, August 5th. The semiconductor company reported $0.11 EPS for the quarter, beating the consensus estimate of $0.09 by $0.02. Silicon Laboratories had a negative net margin of 14.88% and a negative return on equity of 7.21%. The business had revenue of $192.85 million for the quarter, compared to analysts' expectations of $192.57 million. During the same period in the previous year, the company posted ($0.56) EPS. Silicon Laboratories's revenue was up 32.6% on a year-over-year basis. Silicon Laboratories has set its Q3 2025 guidance at 0.200-0.400 EPS. On average, equities research analysts expect that Silicon Laboratories will post -0.97 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Silicon Laboratories news, SVP Brandon Tolany sold 8,000 shares of the business's stock in a transaction on Friday, August 22nd. The shares were sold at an average price of $145.23, for a total transaction of $1,161,840.00. Following the completion of the transaction, the senior vice president owned 62,328 shares of the company's stock, valued at $9,051,895.44. The trade was a 11.38% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Over the last three months, insiders have sold 12,070 shares of company stock worth $1,703,472. 1.60% of the stock is owned by insiders.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of the company. Caxton Associates LLP acquired a new position in Silicon Laboratories during the 2nd quarter worth $255,000. Castleark Management LLC acquired a new position in Silicon Laboratories during the 2nd quarter worth $6,740,000. CANADA LIFE ASSURANCE Co lifted its position in Silicon Laboratories by 4.0% during the 2nd quarter. CANADA LIFE ASSURANCE Co now owns 33,258 shares of the semiconductor company's stock worth $4,899,000 after acquiring an additional 1,269 shares during the last quarter. Tower Research Capital LLC TRC lifted its position in Silicon Laboratories by 116.1% during the 2nd quarter. Tower Research Capital LLC TRC now owns 4,146 shares of the semiconductor company's stock worth $611,000 after acquiring an additional 2,227 shares during the last quarter. Finally, Corient Private Wealth LLC acquired a new position in Silicon Laboratories during the 2nd quarter worth $363,000.

Silicon Laboratories Company Profile

Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.